VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹9.18 Cr | ₹29 Cr | ₹-15 Cr | ₹15 Cr | ₹26 Cr |
What is the latest Net Cash Inflow / Outflow ratio of VENUS REMEDIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹9.18 Cr |
Mar2024 | ₹29 Cr |
Mar2023 | ₹-15 Cr |
Mar2022 | ₹15 Cr |
Mar2021 | ₹26 Cr |
How is Net Cash Inflow / Outflow of VENUS REMEDIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹9.18 Cr | -68.35 | |
Mar2024 | ₹29 Cr | Positive | |
Mar2023 | ₹-15 Cr | Negative | |
Mar2022 | ₹15 Cr | -42.89 | |
Mar2021 | ₹26 Cr | - |
Compare Net Cash Inflow / Outflow of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹617.5 Cr | 2.7% | 2% | 36.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,862.0 Cr | -0.3% | 3.2% | -13% | Stock Analytics | |
DIVIS LABORATORIES | ₹174,458.0 Cr | 7.2% | 8.6% | 6.8% | Stock Analytics | |
CIPLA | ₹125,842.0 Cr | 3% | 0.7% | -2.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,547.0 Cr | -0.5% | NA | 0.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,866.0 Cr | -1.1% | -5.3% | -6.3% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | 2.7% |
2% |
36.8% |
SENSEX | 1% |
0.9% |
1.2% |
You may also like the below Video Courses